Cleared Traditional

K060161 - AFT ALLOGRAFT FILLER TUBE

K060161 is the FDA 510(k) clearance for AFT ALLOGRAFT FILLER TUBE by Musculoskeletal Transplant Foundation. It is a Class 2 Orthopedic device (product code MBP) cleared through the Traditional 510(k) pathway after a 60-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2006
Decision
60d
Days
Class 2
Risk

K060161 is an FDA 510(k) clearance for the AFT ALLOGRAFT FILLER TUBE. Classified as Filler, Bone Void, Osteoinduction (w/o Human Growth Factor) (product code MBP), Class II - Special Controls.

Submitted by Musculoskeletal Transplant Foundation (Edison, US). The FDA issued a Cleared decision on March 21, 2006 after a review of 60 days - a notably fast clearance cycle.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3045 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Musculoskeletal Transplant Foundation devices

Submission Details

510(k) Number K060161 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 20, 2006
Decision Date March 21, 2006
Days to Decision 60 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
62d faster than avg
Panel avg: 122d · This submission: 60d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MBP Filler, Bone Void, Osteoinduction (w/o Human Growth Factor)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3045
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - MBP Filler, Bone Void, Osteoinduction (w/o Human Growth Factor)

All 8
Devices cleared under the same product code (MBP) and FDA review panel - the closest regulatory comparables to K060161.
DBX-H HEMOSTATIC DEMINERALIZED BONE MATRIX PUTTY
K061131 · Orthocon, Inc. · Feb 2007
PROGENIX DBM PUTTY AND PASTE
K060794 · Medtronic Sofamor Danek · Dec 2006
OPTECURE +CCC
K061668 · Exactech, Inc. · Sep 2006
OPTECURE
K050806 · Exactech, Inc. · Feb 2006
OSTEOSET DBM PELLETS
K053642 · Wrightmedicaltechnologyinc · Jan 2006